CASI Pharmaceuticals, Inc. 4
4 · CASI Pharmaceuticals, Inc. · Filed Jun 9, 2017
Insider Transaction Report
Form 4
CAPITELLI SARA B
VP, Finance and PAO
Transactions
- Award
Stock Options (Right to Buy)
2017-06-08+50,000→ 50,000 totalExercise: $1.01Exp: 2027-06-08→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The stock options vest as follows: 25% on the date of grant, and the remainder ratably over three years on a monthly basis.